SALVARANI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.267
EU - Europa 19.199
AS - Asia 3.846
SA - Sud America 100
AF - Africa 69
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 41
Totale 75.576
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.787
GB - Regno Unito 7.898
IT - Italia 3.353
SE - Svezia 2.142
CN - Cina 1.622
DE - Germania 1.530
UA - Ucraina 1.439
TR - Turchia 1.036
FI - Finlandia 909
BG - Bulgaria 744
HK - Hong Kong 657
FR - Francia 394
CA - Canada 226
BZ - Belize 221
IE - Irlanda 208
NL - Olanda 151
JP - Giappone 120
BE - Belgio 108
IN - India 96
VN - Vietnam 68
ES - Italia 58
RU - Federazione Russa 50
CH - Svizzera 46
SG - Singapore 45
AU - Australia 38
EU - Europa 37
IR - Iran 37
KR - Corea 36
MY - Malesia 33
BR - Brasile 30
PL - Polonia 27
TN - Tunisia 27
MX - Messico 26
AR - Argentina 20
ID - Indonesia 18
PT - Portogallo 17
CO - Colombia 16
HU - Ungheria 16
NZ - Nuova Zelanda 16
EG - Egitto 15
RO - Romania 15
CZ - Repubblica Ceca 14
GR - Grecia 13
RS - Serbia 13
CL - Cile 12
PE - Perù 12
IL - Israele 11
AT - Austria 9
DK - Danimarca 9
PK - Pakistan 9
EC - Ecuador 8
IQ - Iraq 8
PH - Filippine 8
TW - Taiwan 8
JO - Giordania 7
KE - Kenya 7
ZA - Sudafrica 7
NO - Norvegia 6
LT - Lituania 5
TH - Thailandia 5
BD - Bangladesh 4
DZ - Algeria 4
EE - Estonia 4
HR - Croazia 4
MA - Marocco 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
LU - Lussemburgo 3
NP - Nepal 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
CU - Cuba 2
GH - Ghana 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
MK - Macedonia 2
SI - Slovenia 2
A1 - Anonimo 1
AL - Albania 1
BN - Brunei Darussalam 1
CY - Cipro 1
GL - Groenlandia 1
GT - Guatemala 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
UG - Uganda 1
VE - Venezuela 1
Totale 75.576
Salva come PNG Salva come JPEG
Città #
Fairfield 8.563
Southend 6.646
Woodbridge 5.897
Houston 4.003
Ashburn 3.523
Chandler 3.385
Seattle 3.114
Wilmington 2.798
Jacksonville 2.731
Cambridge 2.607
Ann Arbor 2.331
Dearborn 1.904
Modena 1.276
Nyköping 1.162
San Diego 983
Princeton 772
Sofia 733
Hong Kong 646
Eugene 557
San Jose 530
Helsinki 455
Beijing 427
Izmir 410
London 378
New York 299
Belize City 221
Redwood City 198
Dublin 183
Las Vegas 159
Milan 145
Chicago 128
Buffalo 127
Boardman 122
Bologna 122
Norwalk 108
Falls Church 105
Dallas 103
Toronto 102
Bremen 95
Saint Louis 95
Brussels 94
Rome 89
Hefei 88
Nanjing 83
Hounslow 79
Reggio Nell'emilia 77
Dong Ket 66
Kunming 66
Chiswick 65
Albuquerque 62
Frankfurt am Main 62
Atlanta 51
Prescot 50
Columbus 49
Guangzhou 41
Jinan 41
North York 38
Des Moines 34
Tokyo 34
Padova 33
Reggio Emilia 31
Florence 30
Vigevano 30
Islington 29
Parma 29
Grafing 28
Nanchang 28
Indiana 27
Ottawa 27
Zurich 27
Shenyang 26
Paris 23
Shanghai 23
Valencia 23
Verona 23
Santa Clara 22
Groningen 21
San Francisco 20
Hebei 19
Acton 18
Bari 18
San Mateo 18
Zhengzhou 18
Chengdu 17
Fuzhou 17
Hangzhou 17
Wuhan 17
Washington 16
Mumbai 15
Rio Saliceto 15
Andover 14
Beauharnois 14
Castenaso 14
Changsha 14
Hanover 14
Ankara 13
Brescia 13
Carpi 13
Catania 13
Fremont 13
Totale 60.152
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 631
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 311
Anti-TNF-α drugs differently affect the TNFa-sTNFR system and monocyte subsets in patients with psoriasis 289
Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy 256
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 254
Comment on: Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis: Reply 252
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 248
Adult Primary Central Nervous System Vasculitis 236
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 223
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease 222
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 220
Prevalence of SARS-CoV-2 (Covid-19) in Italians and in immigrants in an area of Northern Italy (Reggio Emilia) 218
Clinical features of polymyalgia rheumatica and giant cell arteritis 214
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice 201
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 201
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 200
Thalidomide, deep venous thrombosis and vasculitis 199
Clinical Spectrum of Medium-Sized Vessel Vasculitis 191
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 190
Rituximab therapy for Takayasu arteritis: A seven patients experience and a review of the literature 185
Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study 184
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 184
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature 182
Visual loss and other cranial ischaemic complications in giant cell arteritis 181
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 179
Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study 179
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 177
(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 177
Recent advances in the diagnosis and treatment of polymyalgia rheumatica 177
Contrast-enhanced ultrasound of the carotid artery in patients with large vessel vasculitis: Correlation with positron emission tomography findings 175
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility 174
Epidemiology of psoriatic arthritis 174
Biotherapies in large vessel vasculitis 173
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 173
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 172
Improving therapeutic options for patients with giant cell arteritis 171
Validation of the classification criteria for cryoglobulinaemic vasculitis 170
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease 170
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 169
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 167
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 167
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 167
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study 166
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 166
Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis 165
Whole Exome Sequencing Identifies Rare Protein-Coding Variants in Behçet's Disease 165
Trial of Tocilizumab in Giant-Cell Arteritis 165
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 165
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 164
Are steroids alone sufficient for the treatment of giant cell arteritis? 164
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 163
Imaging of vasculitis: State of the art 163
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 163
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 163
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis 162
Primary CNS vasculitis with spinal cord involvement 162
Tocilizumab: a novel therapy for patients with large-vessel vasculitis 161
NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica 161
Management of primary and secondary central nervous system vasculitis 161
Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease? 161
Relationship between plasma profiles of oxytocin and adrenocorticotropic hormone during suckling or breast stimulation in women 160
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 159
Canakinumab in a case of adult onset still's disease: efficacy only on systemic manifestations 159
The role of infectious agents in the pathogenesis of vasculitis 159
Increased expression of interleukin-22 in patients with giant cell arteritis 159
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 159
Biologics in vasculitides: Where do we stand, where do we go from now? 158
A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet's disease 158
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative 158
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine 158
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 158
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial 157
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 157
Rapidly progressive primary central nervous system vasculitis 156
CC chemokine receptor 5 polymorphism in Italian patients with giant cell arteritis 155
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis 154
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 154
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study 154
Idiopathic aortitis: an underrecognized vasculitis 154
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 154
Cervical interspinous bursitis in active polymyalgia rheumatica 153
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease 153
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis 152
Incidence, prevalence and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period 152
Criteria, frequency, and duration of clinical remission in psoriatic arthritis patients with peripheral involvement requiring second-line drugs 152
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study 152
IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population 151
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative 151
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients 151
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 151
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 151
Vasculitis of the gastrointestinal tract in chronic periaortitis 150
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 150
Impact of demography and population dynamics on the genetic architecture of human longevity 150
Pre-pregnancy counselling of patients with vasculitis 150
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 150
Interleukin-10 promoter polymorphisms in giant cell arteritis 150
Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells 150
Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature 149
Treatment of primary CNS vasculitis with rituximab: case report 149
Totale 17.880
Salva come PNG Salva come JPEG
Categoria #
all - tutte 278.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 278.379
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195.938 0 0 0 0 0 579 504 435 121 688 1.943 1.668
2019/202016.678 1.500 623 426 928 2.116 2.624 3.030 1.740 1.694 618 967 412
2020/202115.749 1.381 925 1.143 1.809 1.496 1.116 1.426 1.936 1.014 1.593 917 993
2021/202213.083 614 1.464 1.330 943 364 956 859 630 1.504 938 2.006 1.475
2022/202310.938 1.379 752 733 793 1.297 1.550 254 1.051 1.732 227 627 543
2023/20244.156 351 543 448 862 1.890 62 0 0 0 0 0 0
Totale 77.340